CGEN

Healthcare

Compugen Ltd. · Biotechnology · $260M

UQS Score — Balanced Preset
70.0
Good

Compugen Ltd. scores 70.0/100 using the Balanced preset.

UQS vs Healthcare Sector
CGEN
70.0
Sector avg
32.4
Quality
Strong
Moat
Weak
Growth
Good
Risk
Strong
Valuation
Attractive

Unlock Full CGEN Analysis

Sign in to unlock the detailed analysis behind the UQS Score.

  • Detailed 6-pillar UQS breakdown with exact scores
  • All 29 metrics with sector-calibrated comparisons
  • 6 investor presets (Buffett, Munger, Lynch, Wood, Graham, Balanced)
  • Watchlist tracking with score alerts
  • AI-generated investment perspectives across 6 preset views
  • Score history chart with change notifications
Analyze CGEN in Detail →

Pro Analysis

CGEN — Score History

65707580Apr 2Apr 12Apr 22May 2May 12May 22May 25v5
Score changes· 12 most recent
DateUQSQualityMoatGrowthRiskValueChange
May 12, 202670.098.825.062.5100.098.30.0
May 11, 202670.098.825.062.582.498.30.0
May 10, 202670.098.625.062.582.497.20.0
May 8, 202670.098.625.062.582.497.90.0
May 1, 202670.098.825.062.582.4100.00.0
Apr 26, 202670.098.825.062.582.497.00.0
Apr 25, 202670.098.825.062.582.497.60.0
Apr 23, 202670.098.825.062.582.498.50.0
Apr 22, 202670.098.825.062.582.498.7-0.6
Apr 21, 202670.698.825.062.582.498.50.0

CGEN — Pillar Breakdown

Quality

98.8/100 (25%)

Compugen Ltd. demonstrates outstanding capital efficiency and profitability, placing it among the highest-quality businesses in the market.

Capital Efficiency (ROIC)Strong

How effectively capital is deployed to generate returns.

Return on EquityStrong

Profitability relative to shareholders' equity.

Operating ProfitabilityStrong

Ability to convert revenue into operating profit.

Net ProfitabilityStrong

Bottom-line profit as a share of revenue.

Gross Profit / AssetsStrong

Asset productivity — how much gross profit each dollar of assets generates.

Cash GenerationStrong

Free cash flow relative to market value.

Growth

62.5/100 (20%)

Compugen Ltd. demonstrates healthy growth trends across revenue and earnings.

Recent Revenue TrendStrong

Revenue trajectory over the last twelve months.

3Y Revenue CAGRStrong

Compound annual revenue growth rate over 3 years.

EPS GrowthStrong

Year-over-year earnings per share growth.

Forward Revenue OutlookWeak

Analyst consensus for future revenue growth.

Risk

100.0/100 (15%)

Compugen Ltd. carries minimal financial risk with conservative leverage and strong solvency.

Financial LeverageStrong

Debt levels relative to earnings capacity.

Debt/EquityStrong

Total debt relative to shareholder equity.

Current RatioStrong

Short-term liquidity — ability to pay near-term obligations.

Interest CoverageStrong

Earnings capacity relative to interest payments.

Valuation

99.1/100 (15%)

Compugen Ltd. appears attractively valued relative to its earnings, cash flows, and sector peers.

Earnings YieldStrong

Inverse of forward P/E — higher yield means cheaper stock.

Price to Free Cash FlowStrong

How many years of FCF the market cap represents.

EV/EBITDA vs SectorStrong

Enterprise value multiple relative to sector median.

Moat

25/100 (25%)

Compugen Ltd. operates in a highly competitive environment with limited sustainable advantages. The Moat pillar evaluates competitive advantages across five dimensions: Switching Costs, Network Effects, Cost Advantage, Intangible Assets, and Scale & Ecosystem. Sign in to customize moat ratings for CGEN.

Score Composition

Quality
98.8×25%24.7
Growth
62.5×20%12.5
Risk
100.0×15%15.0
Valuation
99.1×15%14.9
Moat
25.0×25%6.3
Total
70.0Good

Financial Data

More Stock Analysis

How is the CGEN UQS Score Calculated?

The UQS (Unified Quality Score) for Compugen Ltd. is calculated using a proprietary 6-pillar framework with 29 financial metrics. Each pillar evaluates a different dimension on a 0–100 scale, then combines into a single weighted score. Scoring thresholds are calibrated per sector. Momentum is an optional Pro toggle — without it, you get the 5-pillar / 25-metric core shown below.

Quality (25%) measures profitability and capital efficiency — ROIC, ROE, margins, GP/Assets, and FCF Yield.

Moat (25%) assesses Compugen Ltd.'s competitive advantages across switching costs, network effects, cost advantages, intangible assets, and ecosystem scale.

Growth (20%) tracks revenue trajectory and earnings momentum, combining historical results with analyst forward estimates.

Risk (15%) is inversely scored — lower leverage and strong balance sheet health result in higher scores.

Valuation (15%) measures whether Compugen Ltd. is fairly priced using earnings yield, price-to-FCF, PEG ratio, and EV/EBITDA relative to sector peers.

Six investor-inspired presets are available, each with different pillar weights: Balanced, Buffett, Munger, Lynch, Cathie Wood, and Graham. The public score shown here uses the Balanced preset. Learn more in our FAQ.